<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Wang B</submitter><funding>National Natural Science Foundation of China</funding><pagination>101695</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8792265</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>101(3)</volume><pubmed_abstract>Fowl adenovirus serotype 4 (FAdV-4) is the primary causative agent of hepatitis-hydropericardium syndrome (HHS) causing great economic losses to the world poultry industry. The exact factors responsible for the pathogenesis of hypervirulent FAdV-4 have not been completely elucidated. Hypervirulent FAdV-4 infection induces inflammatory damages in accompany with a high level of proinflammatory interleukin-1 beta (IL-1β) secretion in a variety of organs. Investigation of the mechanisms underlying hypervirulent FAdV-4-induced IL-1β secretion would contribute to understanding of the pathogenesis of FAdV-4. Here, we investigated whether FAdV-4 infection activates NLRP3 inflammasome in chicken macrophage cell line HD11. The results showed that stimulation of HD11 with hypervirulent FAdV-4 induced NLRP3- and Caspase-1-dependent secretion of IL-1β. Genetic knockdown of NLRP3 or Caspase-1 expression, a critical component of inflammasome, significantly downregulated IL-1β expression, indicating that activation of the NLRP3 inflammasome contributed to the FAdV-4-induced IL-1β secretion. Moreover, ATP signaling and potassium efflux were involved in the process of NLRP3 inflammasome activation. Our data indicated that hypervirulent FAdV-4 infection induces the activation of NLRP3 inflammasome and followed by massive secretion of IL-1β of macrophages, which thereby contribute to the inflamed lesion of tissues.</pubmed_abstract><journal>Poultry science</journal><pubmed_title>Hypervirulent FAdV-4 infection induces activation of the NLRP3 inflammasome in chicken macrophages.</pubmed_title><pmcid>PMC8792265</pmcid><funding_grant_id>31772771</funding_grant_id><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Song M</pubmed_authors><pubmed_authors>Wang B</pubmed_authors><pubmed_authors>Guo H</pubmed_authors><pubmed_authors>Yang P</pubmed_authors><pubmed_authors>Song C</pubmed_authors><pubmed_authors>Miao Y</pubmed_authors><pubmed_authors>Qiao Q</pubmed_authors><pubmed_authors>Huang Q</pubmed_authors><pubmed_authors>Wang Z</pubmed_authors><pubmed_authors>Zhao J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Hypervirulent FAdV-4 infection induces activation of the NLRP3 inflammasome in chicken macrophages.</name><description>Fowl adenovirus serotype 4 (FAdV-4) is the primary causative agent of hepatitis-hydropericardium syndrome (HHS) causing great economic losses to the world poultry industry. The exact factors responsible for the pathogenesis of hypervirulent FAdV-4 have not been completely elucidated. Hypervirulent FAdV-4 infection induces inflammatory damages in accompany with a high level of proinflammatory interleukin-1 beta (IL-1β) secretion in a variety of organs. Investigation of the mechanisms underlying hypervirulent FAdV-4-induced IL-1β secretion would contribute to understanding of the pathogenesis of FAdV-4. Here, we investigated whether FAdV-4 infection activates NLRP3 inflammasome in chicken macrophage cell line HD11. The results showed that stimulation of HD11 with hypervirulent FAdV-4 induced NLRP3- and Caspase-1-dependent secretion of IL-1β. Genetic knockdown of NLRP3 or Caspase-1 expression, a critical component of inflammasome, significantly downregulated IL-1β expression, indicating that activation of the NLRP3 inflammasome contributed to the FAdV-4-induced IL-1β secretion. Moreover, ATP signaling and potassium efflux were involved in the process of NLRP3 inflammasome activation. Our data indicated that hypervirulent FAdV-4 infection induces the activation of NLRP3 inflammasome and followed by massive secretion of IL-1β of macrophages, which thereby contribute to the inflamed lesion of tissues.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Mar</publication><modification>2025-04-04T07:52:08.669Z</modification><creation>2025-04-04T07:52:08.669Z</creation></dates><accession>S-EPMC8792265</accession><cross_references><pubmed>35077922</pubmed><doi>10.1016/j.psj.2021.101695</doi></cross_references></HashMap>